ENGYSTOL- cynanchum vincetoxicum root and sulfur injection 
MediNatura

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

----------

Engystol 1.1ml Injection

DESCRIPTION

Ingredient name

Potency

Quantity

Final dilution

Asclepias vincetoxicum

6X

6.6 μl

8.22X

Asclepias vincetoxicum

10X

6.6 μl

12.22X

Asclepias vincetoxicum

30X

6.6 μl

32.22X

Sulphur

4X

3.3 μl

6.52X

Sulphur

10X

3.3 μl

12.52X

INDICATIONS AND USAGE

Engystol® Injection Solution is a homeopathic drug product indicated for the support of the immune system to reduce severity and duration of symptoms in viral infections, particularly in the early stages of colds and influenza-like illnesses.

DOSAGE AND ADMINISTRATION

General Considerations

• The dosage schedules listed below can be used as a general guide for the administration of Engystol® Injection Solution.

• Engystol® Injection Solution may be administered s.c., i.d., i.m., or i.v.

• The interval between injections is left to the discretion of the HCP, but should not exceed 1 ampule in 24 hours.

• Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Discard any unused ampule contents.

• Draw up required dose into syringe.

• Discard any unused ampule contents. Do not reuse ampule.

Standard Dosage:

Adults and children 12 years and older: 1 ml 1 to 3 times per 7 days.

Children 6 to 11 years: 0.7 ml 1 to 3 times per 7 days.

Children 2 to 5 years: 0.5 ml 1 to 3 times per 7 days.

Acute Dosage:

Adults and children 12 years and older: 1 ml daily, and then continue with standard dosage.

Children 6 to 11 years: 0.7 ml daily, and then continue with standard dosage.

Children 2 to 5 years: 0.5 ml daily, and then continue with standard dosage.

CONTRAINDICATIONS

Engystol® Injection Solution is contraindicated in patients with known hypersensitivity to Engystol® or any of its ingredients.

WARNINGS AND PRECAUTIONS

None

ADVERSE REACTIONS

Post-marketing Experience

• The following adverse events have been identified during post-marketing use of Engystol® Injection Solution. Because these events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

• Allergic (hypersensitivity) skin reactions may occur in isolated cases.

To report SUSPECTED ADVERSE REACTIONS, contact MediNatura. at 1.844.633.4628 or info@medinatura.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

OVERDOSAGE

No negative effects of an overdose have been reported and none are expected due to the homeopathic dilutions.

CLINICAL PHARMACOLOGY

Mechanism of Action

The exact mechanism of Engystol® Injection Solution is not fully understood.

Pharmacodynamics

Not applicable for homeopathic medicinal products.

DOSAGE

1 ampule containing 1.1 ml solution for injection each containing the active ingredients in the strengths listed under Description.

Engystol 1.1ml Injection.jpg

ENGYSTOL 
cynanchum vincetoxicum root and sulfur injection
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:50114-7015
Route of AdministrationINTRADERMAL, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CYNANCHUM VINCETOXICUM ROOT (UNII: 9R858U917W) (CYNANCHUM VINCETOXICUM ROOT - UNII:9R858U917W) CYNANCHUM VINCETOXICUM ROOT6 [hp_X]  in 1.1 mL
SULFUR (UNII: 70FD1KFU70) (SULFUR - UNII:70FD1KFU70) SULFUR4 [hp_X]  in 1.1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:50114-7015-110 in 1 CARTON05/31/2014
11.1 mL in 1 AMPULE; Type 0: Not a Combination Product
2NDC:50114-7015-23 in 1 CARTON05/31/2014
21.1 mL in 1 AMPULE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved homeopathic05/31/2014
Labeler - MediNatura (102783016)
Establishment
NameAddressID/FEIBusiness Operations
Hameln Pharma GmbH315869123manufacture(50114-7015)
Establishment
NameAddressID/FEIBusiness Operations
Biologische Heilmittel Heel315635359manufacture(50114-7015)

Revised: 3/2019
Document Id: 3b097226-e270-47ff-ab1a-a6d87dcfb55a
Set id: a05158b5-ae28-4889-881c-6a7883c96f4c
Version: 11
Effective Time: 20190326
 
MediNatura